AcuteChlamydia pneumoniaeandMycoplasma pneumoniaeInfections in Community-Acquired Pneumonia and Exacerbations of COPD or Asthma: Therapeutic Considerations

Abstract

Rates of acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections were determined in 115 adults hospitalized for community-acquired pneumonia (CAP), purulent exacerbations of COPD and acute exacerbations of bronchial asthma, by means of serology and molecular methods. Results were compared with those obtained in a matched control group. Common respiratory pathogens were isolated by cultures in 22.5% and 22.2% of CAP and exacerbated COPD patients, respectively. Cultures from exacerbated asthma patients were always negative. Serological and molecular evidence of current C. pneumoniae infection was obtained in 10.0%, 8.9% and 3.3% of CAP, COPD and asthma cases. The corresponding rates of acute M. pneumoniae infection were 17.5%, 6.7% and 3.3%, respectively. Finally, no difference was found between typical and atypical pathogen rates. These findings highlight the importance of taking into account C. pneumoniae and M. pneumoniae infections in guiding the choice of empirical antibacterial treatment for CAP and purulent exacerbations of COPD.

Cigarette smoke extract reduces VEGF in primary human airway epithelial cells

“…Among various bacteria, Mp, an atypical respiratory pathogen, was detected in 6.7% of COPD patients [19]. The significance of Mp colonisation/infection in COPD is largely unknown.…”

“…Mycoplasma pneumoniae (Mp), an atypical respiratory bacterium, is associated with upper as well as lower respiratory tract infections in smokers suffering from COPD [18][19][20]. The impact of bacterial infection on tissue remodelling (e.g.…”

Mycoplasma pneumoniae Infection and Environmental Tobacco Smoke Inhibit Lung Glutathione Adaptive Responses and Increase Oxidative Stress

“…The present study was undertaken to investigate how respiratory pathogens such as M. pneumoniae, which produces oxidative stress and is known to exacerbate lung disease, may interfere with the lung's ability to adapt to ETS. Previous studies have shown that COPD patients may respond differently to community-acquired infections (28,31).…”

Acute Exacerbations and Respiratory Failure in Chronic Obstructive Pulmonary Disease

“…Other viruses, such as parainfluenza virus, adenovirus, and picornavirus, may be important, but their role in AECOPD is less clear. Atypical microorganisms such as Mycoplasma pneumoniae and Chlamydia have been implicated in 5-15% and 5-10% of AECOPD cases, respectively (12,16,17). Patients with infectious exacerbations have longer hospitalizations and greater impairment of several measures of lung function than those with noninfectious exacerbations (8).…”

“…Rhinovirus and respiratory syncytial virus have been implicated as causes for AECOPD in several studies (13)(14)(15)(16)(17). During the influenza season, the prevalent strain of influenza virus may also be an important viral cause, especially in the elderly.…”